Ori · immune intelligence

The immune system is the missing layer in medicine.

Ori reads the immune system over time and connects it to the medical record and to lived experience, to find where disease begins and how to treat it.

Our belief

By dynamically programming the immune system, we can treat all disease.

How it works

We are building the world's most valuable multi-omic, longitudinal immune dataset.

Every month we collect a blood sample, the patient's medical record, and how they're feeling. We structure it into one clean, longitudinal dataset, find the patterns in how each person's immune system changes over time, and analyze what those patterns reveal about disease, then return what we learn to the clinicians treating patients and the companies developing new medicines.

Immune profiling your cells and molecules Clinical context your medical record Lived experience how you feel and live One longitudinal dataset depth · scale · context Patterns and insight returned to care and pharma

A single snapshot can't show how the immune system moves. Following the same people over time, in depth and in context, is the only way to see what changes and why it matters. A dataset like this does not exist.

Where we start

We begin where the immune system has been overlooked.

Conditions long treated as anything but immune, finally given a layer worth measuring, starting with Osteoarthritis and Alzheimer's.

For doctors

Refer the patients medicine keeps failing.

When the labs come back normal but your patient isn't, the answer is often in the immune system, a layer standard care has never been able to measure.

What partnering looks like
01We profile the immune system over time and return what we learn to you.
02No cost to you and no burden on your patient. We handle the consent, logistics, and follow-up.
03We start with Osteoarthritis and Alzheimer's, then the long tail of disease no one has mapped as immune-driven.
04You'll be among the first to see which immune signatures track with disease, and help us design the platform so it's most useful to you.

It adds up to one thing: a better way to diagnose and treat your patients.

Partner with us
For patients

Your biology can move medicine forward.

There are diseases we still cannot cure, because medicine has never had the data to truly see them. The missing piece could be inside you.

By taking part, you help uncover where disease begins and how to treat it. What you contribute could help cure conditions that have no answer today, for you, and for everyone who comes after you.

How it works
01One venous blood draw to begin.
02Each month, we mail a kit to your door.
03A quick finger prick and a short survey, at home.
04Drop it back in the mail.

You're paid for every sample you contribute, and you can earn equity in the company you're helping build. You also keep a clear window into your own immune health.

It takes a few minutes a month, entirely from home, and you're treated as a partner in the science rather than a data point.

Express interest
For pharma

A living readout of human immunity, over time.

Most immune data is a single snapshot. Programs fail because the picture was never complete. Ori follows the same patients for years: deep immune measurement paired with real clinical and patient-reported context.

Too many programs fail late in the clinic, after the biology was finally understood. The immune system had been telling that story for years, if anyone had been measuring it.

01Biomarker discovery & validation.
02Target identification.
03Patient stratification & trial enrichment.
04Mechanistic insight in overlooked indications.
Why it compounds

Each data point and disease we add makes the whole dataset more valuable, and the scientific value compounds.

2 diseases 4 diseases 6 diseases month 1 year 1 year 2 year 3

Each new disease we add makes the whole dataset more valuable, because the immune signal in one condition helps decode the next. By year three we expect to be profiling around six diseases, and that head start can't be bought. It has to be grown, which is exactly what makes it harder to replicate every month.

Especially where no one has looked: indications never mapped as immune-driven, where the targets are still unclaimed. The kind of dataset that takes years to build and can't be bought off the shelf.

Talk to us
scroll